Tag Archives: Cell potency

Baby monkeys born from stem cells

OHSU research demonstrates not all embryonic stem cells are equal; produces the world’s first primate chimeric offspring

Newly published research by scientists at Oregon Health & Science University provides significant new information about how early embryonic stem cells develop and take part in formation of the primate species. The research, which took place at OHSU’s Oregon National Primate Research Center, has also resulted in the first successful birth of chimeric monkeys — monkeys developed from stem cells taken from two separate embryos. The research will be published this week in the online edition of the journal Cell and will be
Read More…

Stem Cells: breakthrough in artificial human organ transplant

Researchers for the first time have been able to demonstrate fully functional complex tissues of human organs i.e. intestines, obtained using stem cell technology, which finds applications in laboratory research as well as medical purposes. The paper was published in the journal Nature.

“This is the first study to demonstrate that human pluripotent stem cells in a petri dish can be instructed to efficiently form human tissue with three-dimensional architecture and cellular composition remarkably similar to intestinal tissue,” said Dr. James Wells, a leading researcher at the Medical Center’s Children’s Hospital of Cincinnati. “The hope is that our ability
Read More…

Policies aimed at curtailing embyronic stem cell research would also hurt iPS cell research, expert finds

Any legislation that slows human embryonic stem cell research is likely to also seriously harm the study of induced pluripotent stem cells, according to a new study by researchers at the Stanford University School of Medicine, the Mayo Clinic and the University of Michigan.

The finding strongly refutes the idea that embryonic stem cell research can be abandoned in favor of the less-controversial iPS cells, which are derived from adult human tissue.

“If federal funding stops for human embryonic stem cell research, it would have a serious negative impact on iPS cell research,” said Stanford
Read More…

Research Team Overcomes Major Obstacle for Stem Cell Therapies and Research

Professor Jeanne Loring

Stem cells show great potential to enable treatments for conditions such as spinal injuries or Lou Gehrig’s disease, and also as research tools. One of the greatest problems slowing such work is that researchers have found major complications in purifying cell mixtures, for instance to remove stem cells that can cause tumors from cells developed for use in medical treatments. But a group of Scripps Research scientists, working with colleagues in Japan, have developed a clever solution to this purification problem that should prove more reliable than other methods, safer, and perhaps 100 times cheaper.

The work
Read More…

Stem Cell Granted Key Patent for Liver Disease

International Stem Cell Corporation, a California-based biotechnology company, today announced that the United States Patent and Trademark Office (USPTO) has granted the Company a patent for a method of creating pure populations of definitive endoderm, precursor cells to liver and pancreas cells, from human pluripotent stem cells. This patent is a key element of ISCO’s metabolic liver disease program and allows the Company to produce the necessary quantities of precursor cells in a more efficient and cost effective manner.

The patent, 8,268,621, adds to the Company’s growing portfolio of proprietary technologies relating to the development of potential treatments
Read More…